Tg Therapeutics (TGTX) Gross Margin (2021 - 2026)
Tg Therapeutics' (TGTX) quarterly Gross Margin came in at 83.65% in Q1 2026, down 349.0% year-on-year from 33.59% in Q1 2025, and up 4.31% quarter-over-quarter from 80.19% in Q4 2025.
Tg Therapeutics (TGTX) Gross Margin (2021 - 2026) Analysis & Trends
Tg Therapeutics' Gross Margin history runs 6 years deep, the most recent figure standing at 83.65% for Q1 2026.
- On a quarterly basis, Gross Margin fell 349.0% year-over-year to 83.65% in Q1 2026; TTM through Mar 2026 was 83.05%, a 437.0% decrease from a year earlier, with the FY2025 full-year figure at 83.66%, down 464.0% from the prior year.
- Gross Margin grew to 83.65% in Q1 2026 per TGTX's latest filing, from 80.19% in the prior quarter.
- Across five years, Gross Margin topped out at 97.88% in Q3 2023 and bottomed at 80.19% in Q4 2025.
- The 5-year median for Gross Margin is 88.11% (2023), against an average of 88.41%.
- Across the five-year window, Gross Margin slumped 1411 bps in 2023 and jumped 363 bps in 2024, its largest moves.
- Year by year, Gross Margin stood at 96.25% in 2022, then slipped by 15 bps to 82.14% in 2023, then gained by 4 bps to 85.77% in 2024, then dropped by 6 bps to 80.19% in 2025, then increased by 4 bps to 83.65% in 2026.
- Per Business Quant, the three latest TGTX Gross Margin figures stand at 83.65% (Q1 2026), 80.19% (Q4 2025), and 82.63% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 83.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.65% |
| Dec 31, 2025 | 80.19% |
| Sep 30, 2025 | 82.63% |
| Jun 30, 2025 | 86.58% |
| Mar 31, 2025 | 87.14% |
| Dec 31, 2024 | 85.77% |
| Sep 30, 2024 | 88.86% |
| Jun 30, 2024 | 88.70% |
| Mar 31, 2024 | 91.43% |
| Dec 31, 2023 | 82.14% |
| Sep 30, 2023 | 97.88% |
| Jun 30, 2023 | 88.11% |
| Mar 31, 2023 | 89.02% |
| Dec 31, 2022 | 96.25% |
| Sep 30, 2022 | 97.87% |
| Mar 31, 2021 | 82.47% |